Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Brain ; 115 ( Pt 3): 783-94, 1992 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1628202

RESUMO

A large-scale clinico-epidemiological study of epileptic seizures has been carried out in a highland area in northern Ecuador, South America. This paper describes the design and the two-staged validation procedures undertaken to authenticate the screening questionnaire, which was used to detect epileptic seizures in the community during this project. An initial questionnaire consisting of 20 questions was devised and then validated in a group of healthy subjects and a group of patients with known epileptic seizures. This questionnaire was found to have a sensitivity of 100% and a specificity of 50.8%. A cluster analysis of the responses rates was undertaken and a set of nine questions which presented a specificity of 92% and sensitivity of 98% were chosen to be used during the survey. The validation of this nine-question instrument was then undertaken by direct application to a general population of 72,121 persons. Positive, negative, false positive and false negative rates were derived. The screening instrument was found to have a sensitivity of 79.3%, a specificity of 92.9%, a positive predictive value of 18.3%, a negative predictive value of 99.6% and a Youden's index of 0.79. The methodology of the study and the instruments developed are recommended for future neuro-epidemiological work in epilepsy. The problems of validation are discussed, and previous epidemiological studies of epilepsy reviewed with special emphasis on the handling of questions of validation.


Assuntos
Métodos Epidemiológicos , Epilepsia/epidemiologia , Inquéritos e Questionários , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Equador/epidemiologia , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade
2.
Neuroepidemiology ; 11(2): 74-84, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1495577

RESUMO

The methodology is presented of a large-scale study of epilepsy carried out in a highland area in northern Ecuador, South America, covering a population of 72,121 people; The study was carried out in two phases, the first, a cross-sectional phase, consisted of a house-to-house survey of all persons in this population, screening for epileptic seizures using a specially designed questionnaire. Possible cases identified in screening were assessed in a cascade diagnostic procedure applied by general doctors and neurologists. Its objectives were: to establish a comprehensive epidemiological profile of epileptic seizures; to describe the clinical phenomenology of this condition in the community; to validate methods for diagnosis and classification of epileptic seizures by a non-specialised team; and to ascertain the community's knowledge, attitudes and practices regarding epilepsy. A sample was selected in this phase in order to study the social aspects of epilepsy in this community. The second phase, which was longitudinal, assessed the ability of non-specialist care in the treatment of epilepsy. It consisted of a prospective clinical trial of antiepileptic therapy in untreated patients using two standard anti-epileptic drugs. Patients were followed for 12 months by a multidisciplinary team consisting of a primary health worker, rural doctor, neurologist, anthropologist, and psychologist. Standardised, reproducible instruments and methods were used. This study was carried out through co-operation between the medical profession, political agencies and the pharmaceutical industry, at an international level. We consider this a model for further large-scale studies of this type.


Assuntos
Países em Desenvolvimento , Epilepsia/epidemiologia , População Rural/estatística & dados numéricos , Convulsões Febris/epidemiologia , Adolescente , Adulto , Carbamazepina/uso terapêutico , Criança , Pré-Escolar , Estudos Transversais , Equador/epidemiologia , Epilepsia/diagnóstico , Epilepsia/tratamento farmacológico , Feminino , Humanos , Incidência , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Fenobarbital/uso terapêutico , Estudos Prospectivos , Convulsões Febris/diagnóstico , Convulsões Febris/tratamento farmacológico
3.
Soc Sci Med ; 31(9): 979-87, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2255970

RESUMO

In just a few years, oral rehydration therapy (ORT) has become the standard treatment to reduce infant diarrhoeal disease mortality in the developing world. The paper describes an ORT intervention campaign in a rural area in Western Kenya (Kakamega District). After about a year of careful preparation, the campaign was launched in January 1986 and compared the use of a value-added product (flavoured sachets) sold through private outlets in addition to primary care distribution of an unflavoured sachet in an experimental cell (Bukura Division). In a control cell (Novakholo Division), only unflavoured sachets were distributed free of charge through primary health care facilities. Using local perceptions of diarrhoeal disease management, the campaign in the experimental cell was carefully designed and mass communication techniques employed and adapted accordingly. Outcome assessments of the campaign, which lasted until March 1987, included the overall ORT utilisation over time. Changes in perceptions towards diarrhoeal disease management, direct assessments of mixing a 'safe and effective' solution accurately and other relevant process parameters were evaluated. Comparing several recent ORT intervention projects, the paper concludes that a combination of a commercial approach and mass communication techniques can further ORS use. If a proper incentive system for shopkeepers is installed and message design and ORS product are fully tailored to the perception and preferences of the target population, the commercial availability of ORS will create an extra demand of the product. However, this will not replace distribution of ORS salts delivered free of charge through primary care sources.


Assuntos
Diarreia Infantil/terapia , Hidratação/estatística & dados numéricos , Educação em Saúde/métodos , Marketing de Serviços de Saúde , Atenção Primária à Saúde/normas , População Rural , Pré-Escolar , Diarreia Infantil/prevenção & controle , Feminino , Educação em Saúde/normas , Humanos , Lactente , Recém-Nascido , Quênia , Masculino , Avaliação de Programas e Projetos de Saúde
5.
N Engl J Med ; 309(2): 67-71, 1983 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-6343878

RESUMO

We conducted a randomized double-blind trial comparing a single dose of trimethoprim-sulfametrole (640 to 3200 mg) with five-day regimens of either trimethoprim-sulfametrole (160 to 800 mg twice daily) or trimethoprim alone (200 mg twice daily) for the treatment of men with chancroid. Of 95 patients, 78 had cultures positive for Hemophilus ducreyi. Twenty-seven, 23, and 28 patients, respectively, were assigned to the single-dose trimethoprim-sulfametrole, the five-day trimethoprim-sulfametrole, and the five-day trimethoprim treatments. The rate of ulcer and bubo resolution, the mean (+/- S.D.) healing times (10.3 +/- 5.7, 11.0 +/- 7.4, and 11.9 +/- 8.2 days, respectively), the microbiologic response, the number of treatment failures, and the number of recurrent ulcers were similar in all three treatment groups. We conclude that single-dose trimethoprim-sulfametrole is a highly effective, inexpensive therapy for chancroid in men and may prove to be an important strategy for the control of H. ducreyi infection.


Assuntos
Cancroide/tratamento farmacológico , Sulfanilamidas/administração & dosagem , Trimetoprima/administração & dosagem , Adulto , Cancroide/microbiologia , Cancroide/patologia , Ensaios Clínicos como Assunto , Método Duplo-Cego , Combinação de Medicamentos , Resistência Microbiana a Medicamentos , Haemophilus ducreyi/efeitos dos fármacos , Haemophilus ducreyi/isolamento & purificação , Hemólise/efeitos dos fármacos , Humanos , Linfonodos/patologia , Masculino , Cooperação do Paciente , Plasmídeos , Sulfanilamidas/efeitos adversos , Trimetoprima/efeitos adversos
6.
Br J Psychiatry ; 142: 379-83, 1983 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-6850176

RESUMO

The prevalence of psychiatric morbidity (PM) was studied among general hospital out-patients in a rural and in a semi-urban area of Kenya. There were no significant differences in the demographic features of psychiatric patients from the two areas, so the results were pooled: this gave a PM prevalence rate of 29 per cent among 388 patients. Anxiety and depression were the most frequent diagnostic categories. Alcoholism was more common in the rural than in the semi-urban area. There was no sex difference in the prevalence of PM and possible reasons for this, which is in contrast to western findings, are discussed. Psychiatric symptoms could be readily elicited when present. Patients showing them had been ill longer than non-PM patients. The study suggests that clinic staff not psychiatrically trained should be able to identify and treat psychiatric morbidity, even when it is presented as somatic illness.


Assuntos
Transtornos Mentais/epidemiologia , População Rural , População Urbana , Adolescente , Adulto , Alcoolismo/epidemiologia , Transtornos de Ansiedade/epidemiologia , Transtorno Bipolar/epidemiologia , Transtorno Depressivo/epidemiologia , Feminino , Humanos , Quênia , Masculino , Pessoa de Meia-Idade , Esquizofrenia/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...